Fig. 6
![Fig. 6](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs40644-019-0241-5/MediaObjects/40644_2019_241_Fig6_HTML.png)
FDG-PET (a) performed for follow-up of a patient with a germline succinate dehydrogenase subunit B mutation and a known left glomus jugulare paraganglioma (arrowhead) demonstrates a new area of FDG-avidity just below the skull base on the right (arrow). The subsequent post-contrast MRI (b) supports that this is a new paraganglioma rather than a metastasis